Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Growth Metrics

Others

ProPhase Labs (PRPH) Short term Debt (2016 - 2025)

Historic Short term Debt for ProPhase Labs (PRPH) over the last 3 years, with Q3 2025 value amounting to $2.7 million.

ProPhase Labs' Short term Debt rose 67.42% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 67.42%. This contributed to the annual value of $1.5 million for FY2016, which is N/A changed from last year.
According to the latest figures from Q3 2025, ProPhase Labs' Short term Debt is $2.7 million, which was up 67.42% from $2.4 million recorded in Q2 2025.
ProPhase Labs' Short term Debt's 5-year high stood at $3.3 million during Q2 2024, with a 5-year trough of $2.4 million in Q1 2024.